Recent Updates
Recently added Catalysts
IPHA Positive Sentiment

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

Thursday, September 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Innate Pharma SA has announced a conference call scheduled for September 17, 2026, to discuss its financial results for the first half of 2026. The call will feature key executives, including the CEO and Chief Medical Officer, who will provide updates on the company's business and strategic direction. This event reflects the company's commitment to transparency and stakeholder engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Innate Pharma is proactive in communicating financial results.
  • The conference call will provide insights into the company's business strategy.
  • Key executives will participate, enhancing transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+103%
120-day peak, hindsight
Typical move
8.5%
average across 2 past catalysts
Lead asset
MIS416
Phase 2 · Secondary Progressive Multiple Sclerosis

Full Press Release Details

MARSEILLE, France--(BUSINESS WIRE)---- $IPH #ADC--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first half of 2026. Participants in the call will be: Jonathan Dickinson, Chief Executive Officer Markus Jensen, Vice President, Chief Medical Officer Yannis Morel, Executive Vice President, Chief Op

Frequently Asked Questions

When is Innate Pharma's conference call scheduled?

The conference call is scheduled for September 17, 2026, at 2:00 p.m. CEST.

Who will participate in the conference call?

Key executives, including the CEO and Chief Medical Officer, will participate.

What will be discussed during the call?

The call will provide a business update and financial results for the first half of 2026.

Where can I find the conference call details?

Details for the conference call can be found in the company's regulatory news release.

ShareAdd on Google
Tags: IPHA Viatris Investor Conferences Healthcare Innate Pharma financial results business update conference call
Last updated: Sep 10, 2026

Biotech snapshot

Lead asset
MIS416Phase 2
Secondary Progressive Multiple Sclerosis →

Catalyst track record

+103%
best trade around IPHA's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IPHA.

See every catalyst's timing & PoA →